Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples.
PMID 41759529 · PMC13036604 · Molecular cell · 2026 · 8 claims · 8 setups
An optimized dual-lentiviral CRISPR-Cas9 knockout system with fluorescent markers, SFFV promoter, and improved sgRNA backbone (LRG2.1) achieves efficient, low-toxicity gene editing in AML PDX and primary patient samples
-
Full-text index only
RMzyme: regulations of RNA-modifying enzymes in humans.
PMID 41672979 · PMC12895048 · Signal transduction and targeted therapy · 2026 · 8 claims · 7 setups
RMzyme is a comprehensive multiomics knowledgebase covering 179 human RNA-modifying proteins across 18 major RNA modification types and 63 human tissues
-
Full-text index only
In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions.
PMID 17201911 · PMC1774567 · BMC genomics · 2007 · 8 claims · 5 setups
A computational EST-based pipeline can identify UTR-SNPs that are statistically over-represented in cancerous versus normal tissue libraries
-
Full-text index only
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?
PMID 17595663 · PMC2360307 · British journal of cancer · 2007 · 8 claims · 14 setups
A SNP in the cytidine deaminase (CDA) gene (208G>A, haplotype *3) decreases gemcitabine clearance, increases Cmax/AUC, and increases neutropenia risk when gemcitabine is combined with platinum drugs or 5-FU